Real-time enrollment status for this locally advanced unresectable or metastatic solid tumors clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:14 PM UTC
| NCT Number | NCT05458219 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced Unresectable or Metastatic Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 470 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Innovent Biologics (Suzhou) Co. Ltd. |
| Last Updated on CT.gov | May 4, 2026 (May 4, 2026) |
As of July 13, 2026: Clinical trial NCT05458219 is currently recruiting participants. This clinical trial study for locally advanced unresectable or metastatic solid tumors is actively seeking new participants at 3 locations across the United States. The study is sponsored by Innovent Biologics (Suzhou) Co. Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05458219 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05458219 was last updated May 4, 2026 (May 4, 2026). HelloStudys verifies this status automatically.